Reports to FDA of fatal anaphylaxis associated with intravenous iron products

Am J Hematol. 2016 Dec;91(12):E496-E497. doi: 10.1002/ajh.24531. Epub 2016 Aug 29.

Authors

Lynda McCulley¹, Kate Gelperin¹, Steven Bird¹, Sarah Harris¹, Cunlin Wang¹, Peter Waldron¹

Affiliation

¹ U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), Office of Pharmacovigilance and Epidemiology, Silver Spring, Maryland.

PMID: 27508336
DOI: 10.1002/ajh.24531

No abstract available

Publication types

Letter

MeSH terms

Administration, Intravenous
Adult
Aged
Aged, 80 and over
Anaphylaxis / etiology*
Anaphylaxis / mortality
Drug Approval / methods*
Female
Humans
Iron / adverse effects*
Male
Middle Aged
United States
Young Adult

Substances

Iron